Active Clinical Trials

PreFaiR

 

Comparative Effectiveness of Pregnancy Failure Management Regimens

 

This is an NIH-funded research study investigating a new treatment option for the medical management of early pregnancy loss. It compares the current standard of care, a medication called misoprostol, to a combination treatment of a drug called mifepristone taken in addition to misoprostol.  We are trying to determine which option works better.  The combination treatment is already used successfully in women desiring induced abortion in early pregnancy.  We are also looking at the biology of miscarriage to predict which women are most likely to succeed with medical management of early pregnancy loss. 

Subject participation will last for 30 days and participants will receive a total of $250 for study completion.  

Qualified participants: 
•    Good general health
•    Women 18 years or older
•    Between 5 and 12 weeks pregnant
•    Diagnosed with early pregnancy loss
•    Willing to use medical management to help pass the pregnancy
•    Willing to be randomized to one of the two treatment arms. 

 

Principal Investigator:
Dr. Courtney A. Schreiber, MD, MPH

Sponsor:
NIH

Penn Family Planning research phone number: 
(215) 615-0381

clinicaltrials.gov listing

Recruiting from clinical population only

Clinical Trials Now Recruiting!

Active Clinical Trials

Fertility and the BRCA gene

Studies on the Epigenetic Regulation of Human Pregnancy in  Fertile and Infertile Couples and Placental Parameters Sub-Study

Infertility

Paid research study seeking healthy women who are not at risk for pregnancy

Infertility study

Non-hormonal intrauterine device